Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Evaluation of the overall IFN-gamma and IL-17 pro-inflammatory responses after DNA therapy of tuberculosis

Texto completo
Autor(es):
Mostrar menos -
Zarate-Blades, Carlos R. [1] ; Rodrigues, Rodrigo F. [1] ; Souza, Patricia R. M. [1] ; Rios, Wendy M. [1] ; Soares, Luana S. [1] ; Rosada, Rogerio S. [1] ; Brandao, Izaira T. [1] ; Masson, Ana Paula [1] ; Floriano, Elaine M. [2] ; Ramos, Simone G. [2] ; Silva, Celio L. [1]
Número total de Autores: 11
Afiliação do(s) autor(es):
[1] Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Biochem & Immunol, Ctr TB Res, Sao Paulo - Brazil
[2] Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Pathol, Sao Paulo - Brazil
Número total de Afiliações: 2
Tipo de documento: Artigo Científico
Fonte: HUMAN VACCINES & IMMUNOTHERAPEUTICS; v. 9, n. 5, p. 1093-1103, MAY 1 2013.
Citações Web of Science: 9
Resumo

Despite the enormous efforts displayed globally in the fight against tuberculosis, the disease incidence has modified slightly, which has led to a renewed interest in immunotherapy. In general, successful immunotherapeutic candidates against tuberculosis are agents that can trigger strong, specific pro-inflammatory responses, especially of the T-helper (Th) 1 pattern. However, how these pro-inflammatory agents effectively kill the bacteria without eliciting immunopathology is not well understood. We reasoned that, in addition to the specific immune response elicited by immunotherapy, the evaluation of the overall pro-inflammatory responses should provide additional and valuable information that will be useful in avoiding immunopathology. We evaluated the overall IFN- and IL-17 pro-inflammatory responses among CD4(+), CD8(+) and T cells in the lungs of mice that were infected with M. tuberculosis and treated with a DNA vaccine in an immunotherapeutic regimen. Our results demonstrate that mice that effectively combat the pathogen develop a strong, specific Th1 immune response against the therapeutic antigen and have reduced lung inflammation, present in parallel a fine-tuning in the total IFN-- and IL-17-mediated immunity in the lungs. This modulation of the total immune response involves reducing the Th17 cell population, augmenting CD8(+) T cells that produce IFN- and increasing the total T cell frequency. These results stress the importance of a broad evaluation of not only the specific immune response at the time to evaluate new immune interventional strategies against tuberculosis but also non-conventional T cells, such as T lymphocytes. (AU)

Processo FAPESP: 06/05963-8 - Avaliação de células T gamma-delta como linfócitos efetores e células apresentadoras de antígenos na profilaxia e imunoterapia da tuberculose com vacinas de DNA
Beneficiário:Carlos Rodrigo Zarate Blades
Modalidade de apoio: Bolsas no Brasil - Pós-Doutorado